Wang et al. [39] demonstrated that the knockdown of Zeb2 via RosaERT2 Cre-mediated knockout in the mouse AML model derived from the MLL-AF9 oncogene led to the delay of leukemia progression. This evidence concerns the gene ZEB2 and acute myeloid leukemia.